Indian pharmaceutical giant Wockhardt is exploring a sale. The company, known for its extensive portfolio of generic and branded pharmaceuticals, has been facing difficulties in recent quarters. Sources close to the negotiations suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international companies. A fina